Literature DB >> 4043168

Human tumour pH and its variation.

J L Wike-Hooley, A P van den Berg, J van der Zee, H S Reinhold.   

Abstract

The variation in human tumour pH values is large. The aim of this study was to analyse the reasons for these large variations and to determine whether tumour pH can be predicted on the basis of any easily measured parameter. One hundred and five determinations of tumour pH were performed in various human tumours, using the Philips C 902S tissue pH electrode. No correlations were found between the tumour pH and the tumour histology, degree of differentiation, tumour size, patient age or treatment history, and whether or not the tumour was ulcerated. However, tumour pH was significantly lower in primary tumours than in lymph node metastases. Tumours at their primary site (primary, recurrent or residual) were also more acid than distant metastases. The vascular disruption caused by the measuring technique was found to be acceptable.

Entities:  

Mesh:

Year:  1985        PMID: 4043168     DOI: 10.1016/0277-5379(85)90216-0

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  24 in total

1.  In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines.

Authors:  Yogesh Kumar; Sybille Mazurek; Shiyu Yang; Klaus Failing; Marc Winslet; Barry Fuller; Brian R Davidson
Journal:  Tumour Biol       Date:  2010-02-24

2.  Modeling and simulation of chemomechanics at the cell-matrix interface.

Authors:  Ranjani Krishnan; Binu Oommen; Emily B Walton; John M Maloney; Krystyn J Van Vliet
Journal:  Cell Adh Migr       Date:  2008-04-17       Impact factor: 3.405

3.  Tumorigenic 3T3 cells maintain an alkaline intracellular pH under physiological conditions.

Authors:  R J Gillies; R Martinez-Zaguilan; G M Martinez; R Serrano; R Perona
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours.

Authors:  Pavel S Yarmolenko; Yulin Zhao; Chelsea Landon; Ivan Spasojevic; Fan Yuan; David Needham; Benjamin L Viglianti; Mark W Dewhirst
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.

Authors:  S Jouan-Lanhouet; M I Arshad; C Piquet-Pellorce; C Martin-Chouly; G Le Moigne-Muller; F Van Herreweghe; N Takahashi; O Sergent; D Lagadic-Gossmann; P Vandenabeele; M Samson; M-T Dimanche-Boitrel
Journal:  Cell Death Differ       Date:  2012-07-20       Impact factor: 15.828

6.  Stimulus-responsive hydrogels: Theory, modern advances, and applications.

Authors:  Michael C Koetting; Jonathan T Peters; Stephanie D Steichen; Nicholas A Peppas
Journal:  Mater Sci Eng R Rep       Date:  2015-05-16       Impact factor: 36.214

7.  Interaction of ASIC1 and ENaC subunits in human glioma cells and rat astrocytes.

Authors:  Niren Kapoor; William Lee; Edlira Clark; Rafal Bartoszewski; Carmel M McNicholas; Cecelia B Latham; Zsuzsanna Bebok; Vladimir Parpura; Catherine M Fuller; Cheryl A Palmer; Dale J Benos
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-23       Impact factor: 4.249

8.  Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer.

Authors:  Naveen K Thakral; Alok R Ray; Daniel Bar-Shalom; André Huss Eriksson; Dipak K Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-11-22       Impact factor: 3.246

9.  Remotely triggered cisplatin release from carbon nanocapsules by radiofrequency fields.

Authors:  Mustafa Raoof; Brandon T Cisneros; Adem Guven; Sophia Phounsavath; Stuart J Corr; Lon J Wilson; Steven A Curley
Journal:  Biomaterials       Date:  2012-12-08       Impact factor: 12.479

10.  Concentration-independent pH detection with a luminescent dimetallic Eu(III)-based probe.

Authors:  Jeremiah D Moore; Richard L Lord; G Andrés Cisneros; Matthew J Allen
Journal:  J Am Chem Soc       Date:  2012-10-15       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.